Nano-X Imaging Ltd. (NNOX)
| Previous close | 6.24 |
| Open | 6.24 |
| Bid | 6.51 x 900 |
| Ask | 6.52 x 1800 |
| Day's range | 6.08 - 6.51 |
| 52-week range | 5.31 - 22.69 |
| Volume | |
| Avg. volume | 1,057,422 |
| Market cap | 358.327M |
| Beta (5Y monthly) | 1.58 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.89 |
| Earnings date | 08 Nov 2023 - 13 Nov 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 26.17 |
GlobeNewswireNanox.AI’s HealthCCSng AI Solution Reveals ~60% of Patients in Study had Previously Undetected Risk of a Cardiovascular Event from Routine Chest CTs
Beilinson Hospital in Israel used Nanox.AI’s HealthCCSng solution to conduct study on routine chest CT scans to assess impact of AI-based coronary artery calcium (CAC) measurements Nanox.AI’s HealthCCSng solution utilizes medical imaging data from routine chest CT scans to automatically quantify and analyze CAC category Majority of patients needed to be referred to either specialized preventive cardiology clinics or primary care physicians for further evaluation and treatment CAC scoring is stro
- GlobeNewswire
Nanox to Present at the Cantor Fitzgerald Global Healthcare Conference 2023 in September
NEVE ILAN, Israel, Sept. 13, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced its participation in the Cantor Fitzgerald Global Healthcare Conference 2023, which will be held on September 26-28, 2023 at the InterContinental Barclay Hotel in New York City. Nanox’s Chief Executive Officer, Erez Meltzer, and Chief Financial Officer, Ran Daniel, will engage in a fireside chat and host investor 1x1
Motley Fool3 Magnificent Growth Stocks to Buy on the Dip
Growth stocks have lost momentum in August after a strong start to the year. Innovative companies in the fields of drug development and medical imaging, such as Agenus (NASDAQ: AGEN), BioCryst Pharmaceuticals (NASDAQ: BCRX), and Nano-X Imaging (NASDAQ: NNOX) have all experienced a significant drop in their stock prices in the past 30 days.
